Budesonide/formoterol
Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
... of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstruc- tive pulmonary disease (COPD): effect on COPD-related ...
7
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol
... both budesonide/formoterol and formot- erol was well tolerated and systemic effects were similar for both ...the budesonide/formoterol and formoterol groups, ...the ...
9
Once- vs Twice-Daily Budesonide/Formoterol in 6- to 15-Year-Old Patients With Stable Asthma
... In this 12-week, multicenter (95 US centers), double-blind, parallel- group, active-controlled, randomized study (www.clinicaltrials.gov identi- fier NCT00646321; www.astrazeneca clinicaltrials.com identifiers SD-039- 0725 ...
13
Budesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD A double-blind, randomised, non-inferiority, parallel-group, multicentre study
... the budesonide/formoterol group and the prednisolone plus formoterol ...the budesonide/formot- erol group does not alter this conclusion as these were clearly unrelated to the randomized ...
11
Satisfaction levels and asthma control amongst Malaysian asthmatic patients on budesonide/formoterol maintenance and reliever therapy: experience in a real-life setting
... of satisfaction were significantly increased compared with previous treatment regimes, the greatest increase occurred in the domain of effectiveness. This subjective perception of improved efficacy is supported by ...
8
<p>Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis</p>
... application: budesonide/for- moterol, fluticasone propionate/salmeterol, and mometasone ...whether budesonide/formoterol increases the risk of pneumonia or the risk of other ICS-related adverse ...
10
Long-term maintenance of pediatric asthma: focus on budesonide/formoterol inhalation aerosol
... either budesonide/formoterol ...plus budesonide/formoterol ...or budesonide 160 µ g bid as maintenance therapy plus terbutaline ...the budesonide/formoterol combination ...
11
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide–formoterol Spiromax® compared to budesonide–formoterol Turbuhaler® in adults and adolescents with persistent asthma
... 5 Differences in mean Spiromax PASAPQ scores vs mean Turbuhaler PASAPQ scores at baseline * and week 12 * ( a ) performance domains ( b ) convenience domains. BFT budesonide – formoterol[r] ...
11
Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study
... Furthermore, budesonide/ formoterol is also effective in situations of acute and severe bronchoconstriction [8,9], indicating that it is effective as a reliever ...that budesonide/formoterol ...
9
Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study
... using budesonide/formoterol maintenance and reliever therapy in different countries/areas within the general practice setting, by assessing the change in ACQ-5 score from baseline at country/area level; ...
12
Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial
... inhaled budesonide/ formoterol combination with budesonide/salbutamol delivered by metered dose inhaler with a spacer in acute exacerbation of asthma in ...inhaled budesonide/ ...
7
Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes
... of budesonide/formoterol pMDI in patients with persistent asthma, with a particular focus on patient-reported outcomes (eg, perceived onset of effect, patient satisfaction with treatment, health-related ...
15
Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation
... Of the 165 patients who were diagnosed with BOS in the pulmonology department from January 2011 to June 2015, 61 patients met the inclusion criteria. Patients’ basic characteristics are shown in Table 1. All patients ...
9
Budesonide/formoterol combination in COPD: a US perspective
... Abstract: Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease of the lung caused primarily by exposure to cigarette smoke. Clinically, it presents with progres- sive cough, sputum ...
10
Budesonide/Formoterol Combination Therapy as Both Maintenance and Reliever Medication in Moderate to Severe Asthma: A Real Life Effectiveness Study of Malaysian Patients
... difference = 2.5%, p=0.015; mean difference: 90 ml, p=0.013] showed significant improvement while in comparator, there was significant improvement only in the requirement for rescue treatment (p=0.023). Hospital ...
5
Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
... In conclusion, data from this study show that treatment with an ICS/LABA combination has important clinical impact irrespective of disease severity; these effects are evid[r] ...
13
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps
... containing budesonide and formoterol for both maintenance ther- apy and relief of symptoms (option for Steps ...of budesonide (a Step 2-3 option) [3,4], the same dose of ICS plus a LABA (a Step 3 ...
11
Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study
... Fig. a Randomization into cross-over phase; b Randomization into longitudinal phase; patients meeting the inclusion criteria: step 3 or 4 asthma therapy as defined by BTS guidelines for [r] ...
14
A Study on Budesonide/ Formoterol vs. Fluticasone/ Salmeterol Inhaled Combination in Moderate to Severe Asthma
... primary efficacy variable were both statistically and clin- ically significant, supporting the fact that this study had the power to detect any potential difference between groups, although the minimum dose required to ...
6
Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment
... This study also considers a problem common in clin- ical practice, that is, the situation in which patients use higher than recommended levels of reliever use before they or their physicians step up treatment [18]. The ...
8